FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4018011000001107: Zinc oxide 6.6% / Lidocaine 0.7% ointment (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
14992101000001118 Zinc oxide 6.6% / Lidocaine 0.7% ointment (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
14992201000001113 Zinc oxide 6.6% / Lidocaine 0.7% ointment en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zinc oxide 6.6% / Lidocaine 0.7% ointment Is a Zinc oxide + Lidocaine true Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Topical route false Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Rectal route true Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route ointment.cutaneous ontology form and route true Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route ointment.rectal ontology form and route true Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment Has NHS dm+d (dictionary of medicines and devices) dose form indicator Continuous dose form indicator true Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment Has active ingredient Zinc oxide false Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Cutaneous true Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment Has active ingredient Lidocaine hydrochloride false Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment Is a Product containing lidocaine and zinc oxide false Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment Has specific active ingredient Lidocaine hydrochloride true Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment Has specific active ingredient Zinc oxide true Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment Has active ingredient Lidocaine false Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment Has dispensed dose form Ointment true Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Germoloids ointment (Bayer Plc) Is a True Zinc oxide 6.6% / Lidocaine 0.7% ointment Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment 15 ml Is pack of False Zinc oxide 6.6% / Lidocaine 0.7% ointment Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment 55 ml Is pack of False Zinc oxide 6.6% / Lidocaine 0.7% ointment Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment 25 ml Is pack of False Zinc oxide 6.6% / Lidocaine 0.7% ointment Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment 55 ml Has VMP True Zinc oxide 6.6% / Lidocaine 0.7% ointment Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment 25 ml Has VMP True Zinc oxide 6.6% / Lidocaine 0.7% ointment Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment 15 ml Has VMP True Zinc oxide 6.6% / Lidocaine 0.7% ointment Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start